Ga-DOTATOC Versus Octreoscan + CT
Learn more about:
Related Access Program
Related Clinical Trial
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
Ga-DOTATOC Versus Octreoscan + CT
Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors